A Systematic Review and Economic Model

Total Page:16

File Type:pdf, Size:1020Kb

A Systematic Review and Economic Model Health Technology Assessment 2009; Vol. 13: No. 38 The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model M Bond, M Pitt, J Akoh, T Moxham, M Hoyle and R Anderson August 2009 DOI: 10.3310/hta13380 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph. You can order HTA monographs from our Despatch Agents: – fax (with credit card or official purchase order) – post (with credit card or official purchase order or cheque) – phone during office hours (credit card only). Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: HTA Despatch Email: [email protected] c/o Direct Mail Works Ltd Tel: 02392 492 000 4 Oakwood Business Centre Fax: 02392 478 555 Downley, HAVANT PO9 2NP, UK Fax from outside the UK: +44 2392 478 555 NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30–40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit card The following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD? Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide. The website also provides information about the HTA programme and lists the membership of the various committees. Abstract ........................................................... iii Glossary and list of abbreviations .................... vii The effectiveness and cost-effectiveness Executive summary .......................................... xi of methods of storing donated kidneys Chapter 1 Acknowledgements .......................... 91 Background ............................................... 1 from deceased donors: a systematic Description of the problem ....................... 1 References ........................................ 93 Current service provision ........................... 7 review and economic model Description of technology under assessment 9 Appendix 1 Literature searching strategies . 99 Chapter 2 Definition of the decision problem ........... 13 1* 1 2 1 Appendix 2 Decision problem ....................................... 13 M Bond, M Pitt, J Akoh, T Moxham, Study identification .................... 105 Overall aims and objectives ....................... 13 1 1 M Hoyle and R Anderson Appendix 3 Chapter 3 Data extraction tables ............... 107 1 Assessment of clinical effectiveness .......... 15 Peninsula Technology Assessment Group (PenTAG), Peninsula Medical Methods for reviewing effectiveness .......... 15 School, Universities of Exeter and Plymouth, UK Appendix 4 Results ........................................................ 17 2Derriford Hospital, Plymouth Hospitals NHS Trust, UK Excluded studies ......................... 133 Assessment of effectiveness ........................ 18 Safety ......................................................... 30 *Corresponding author Appendix 5 Subgroups .................................................. 31 Flow of kidneys in the Machine Preservation Summary of clinical effectiveness .............. 31 Trial ............................................. 139 Declared competing interests of authors: J Akoh is part of the investigating research Chapter 4 Appendix 6 Assessment of cost-effectiveness .............. 35 team for one of the sites of the PPART trial. CHEC list assessment of economic evaluations Some economic aspects of kidney preservation methods ................................................ 141 ............................................................. 35 Systematic review of existing cost-effectiveness evidence Appendix 7 ............................................................. 35 PenTAG model transitions ......... 143 Assessment of industry submissions to NICE 38 The PenTAG cost–utility assessment ......... 38 Appendix 8 Model parameters – the standard data set 42 Base-case outputs from the PenTAG model by age Results of PenTAG cost–utility analysis ...... 55 group .......................................... 145 One-way sensitivity analysis ....................... 66 Probabilistic sensitivity analysis ................. 71 Appendix 9 Summary of cost-effectiveness ................... 78 Hazard ratios for graft survival .. 149 Chapter 5 Appendix 10 Assessment of factors relevant to the NHS and other Published August 2009 Probabilistic sensitivity analyses 151 parties ........................................................ 79 DOI: 10.3310/hta13380 The use of machine perfusion to predict the viability of Health Technology Assessment reports published to kidneys ................................................... 79 date ............................................ 157 Safety and ease of use of machine perfusion and cold This report should be referenced as follows: storage ................................................... 80 Health Technology Assessment Systems and regulations for organ retrieval and transport Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R. The effectiveness and cost- programme ................................ 177 ............................................................. 80 effectiveness of methods of storing donated kidneys from deceased donors: a systematic Impact of dialysis versus transplantation on employment review and economic model. Health Technol Assess 2009;13(38). status ...................................................... 80 Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta Chapter 6 Medica/EMBASE, Science Citation Expanded (SciSearch) and Current Contents/Clinical Discussion .................................................. 83 Principal findings ...................................... 83 Medicine. Strengths and limitations of the systematic review of clinical effectiveness ........................................... 85 Strengths and limitations of the cost–utility analysis 85 Other relevant factors ................................ 88 Chapter 7 Conclusions ................................................ 89 Implications for service provision ............. 89 Suggested research priorities ..................... 89 NIHR Health Technology Assessment programme he Health Technology Assessment (HTA) programme, part of the National Institute for Health TResearch (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘Health technologies’ are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the ‘National Knowledge Service’. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, from the public and consumer groups and from professional bodies such as royal colleges and NHS trusts. These suggestions are carefully prioritised by panels of independent experts (including NHS service users). The HTA programme then commissions the research by competitive tender. Second, the HTA programme provides grants for clinical trials for researchers who identify research questions. These are assessed for importance to patients and the NHS, and scientific rigour. Third, through its Technology Assessment Report (TAR) call-off contract, the HTA programme commissions bespoke reports, principally for NICE, but also for other policy-makers. TARs bring together evidence on the value of specific technologies. Some HTA research projects, including TARs, may take only months, others
Recommended publications
  • 8 Tissue Preservation Kelvin G.M
    2772_C008.fm Page 157 Thursday, June 15, 2006 9:47 AM 8 Tissue Preservation Kelvin G.M. Brockbank and Michael J. Taylor CONTENTS 8.1 Introduction...........................................................................................................................157 8.2 Short-Term Tissue Preservation ...........................................................................................159 8.2.1 Hypothermic Storage of Tissues: Illustrative Studies Using Blood Vessels............................................................................................................161 8.2.2 Basic Rationale for the Design of Hypothermic Solutions.....................................162 8.3 Tissue Screening, Preparation, and Antibiotic Sterilization................................................166 8.4 Cryopreservation...................................................................................................................169 8.4.1 Synthetic Cryoprotectants ........................................................................................170 8.4.2 Natural Cryoprotectants............................................................................................172 8.4.3 Cryopreservation by Controlled Freezing................................................................173 8.4.4 Cryopreservation by Avoidance of Ice Formation — Vitrification .........................174 8.4.5 Vitrification Versus Freezing ....................................................................................176 8.4.6 Microencapsulated Cells
    [Show full text]
  • Islet Isolation from Juvenille Porcine Pancreas After 24H Hypothermic
    Islet Isolation from Juvenile Porcine Pancreas after 24h Hypothermic Machine Perfusion Preservation Michael J. Taylor, Ph.D1,3, Simona Baicu, PhD1, Elizabeth Greene1, Alma Vazquez1, John Brassil2. 5 1Cell and Tissue Systems, N. Charleston, SC 29406, USA, 2LifeLine Scientific, Des Plaines, IL 60018, USA. 3 Dept. Surgery, Medical University of South Carolina, Charleston, SC 29425, USA. 10 Suggested Running Head: Perfusion preservation of pig pancreas for islets Corresponding Author: 15 Michael J Taylor, Ph.D. VP Research and Development Cell and Tissue Systems, Inc. 2231 Technical Parkway, Suite A, N. Charleston, SC 29406, USA 20 Ph: (843)722-6756 Fax: (843) 722-6657 EM: [email protected] 25 ABSTRACT Pancreas (Px) procurement for islet isolation and transplantation is limited by concerns for the detrimental effects of post-mortem ischemia. Hypothermic machine perfusion (HMP) preservation technology has had a major impact in circumventing ischemic injury in 5 clinical kidney transplantation and is applied here to the preservation and procurement of viable islets after hypothermic perfusion preservation of porcine pancreata since pigs are now considered the donor species of choice for xenogeneic islet transplantation. Methods: Pancreases were surgically removed, from young (<6 months) domestic Yorkshire pigs (25-30 kg), either before or after 30min of warm ischemia time (WIT) and 10 cannulated for perfusion. Each Px was assigned to one of six preservation treatment groups: Fresh controls: processed immediately (cold ischemia<1h) [G1,n=7], Static Cold Storage: flushed with cold UW-Viaspan and stored in UW-Viaspan at 2-4ºC for 24h with no prior WIT [G2,n=9], HMP-perfused on a LifePort® machine at 4-6ºC and low pressure (10mmHg) for 24h with either KPS1 solution (G3, n=7) or Unisol-UHK (G4, n=7).
    [Show full text]
  • Organ Preservation Into the 2020'S: the Era of Dynamic Intervention
    Organ Preservation into the 2020's: the Era of Dynamic Intervention Authors: Alexander Petrenkoa, Matias Carnevaleb,c, Alexander Somova, Juliana Osoriob, Joaquin Rodríguezb, Edgardo Guibert b,c, Barry Fullerd, Farid Froghid Affiliations: a Department of Cryobiochemistry, Institute for Problems of Cryobiology and Cryomedicine, Ukraine Academy of Sciences, Kharkov, Ukraine b Centro Binacional (Argentina-Italia) de Investigaciones en Criobiología Clínica y Aplicada (CAIC), Universidad Nacional de Rosario, Rosario, Argentina c Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina d UCL Division of Surgery and Interventional Sciences, Royal Free Hospital, London, United Kingdom Corresponding author: Mr Farid Froghi University College London Division of Surgery and Interventional Sciences Royal Free Hospital, Pond Street London, NW3 2QG United Kingdom [email protected] 1 Abstract: Organ preservation has been of major importance ever since transplantation developed into a global clinical activity. The relatively simple procedures were developed on a basic comprehension of low temperature biology as related to organs outside the body. In the past decade, there has been a significant increase in knowledge of the sequelae of effects in preserved organs, and how dynamic intervention by perfusion can be used to mitigate injury and improve the quality of the donated organs. The present review focuses (1) on new information about the cell and molecular events impacting on ischaemia / reperfusion injury during organ preservation; (2) strategies which use varied compositions and additives in organ preservation solutions to deal with these; (3) clear definitions of the developing protocols for dynamic organ perfusion preservation; (4) information on how the choice of perfusion solutions can impact on desired attributes of dynamic organ perfusion; (5) summary and future horizons.
    [Show full text]
  • 2 Biology of Cell Survival in the Cold
    2772_C002.fm Page 15 Wednesday, July 5, 2006 8:11 AM Biology of Cell Survival in the 2 Cold: The Basis for Biopreservation of Tissues and Organs Michael J. Taylor CONTENTS 2.1 Introduction.............................................................................................................................16 2.2 The Cell in Relation to Its Environment ...............................................................................17 2.2.1 Differences between the Extracellular Environment and the Intracellular Milieu, and Their Control ..........................................................................................17 2.2.1.1 Osmotic Cell Swelling ...............................................................................18 2.2.2 Essential Maintenance Processes ...............................................................................19 2.2.3 Essential Role of the Circulation ...............................................................................19 2.3 A Synopsis of Ischemic and Hypoxic Injury .......................................................................20 2.3.1 The Ischemic Cascade................................................................................................21 2.3.2 Structural Changes......................................................................................................23 2.3.3 Vascular Injury During and Subsequent to Ischemia ...............................................23 2.3.4 No-Reflow...................................................................................................................24
    [Show full text]
  • Cold Storage of Liver Microorgans in Viaspan® and BG35 Solutions
    ORIGINAL ARTICLE March-April, Vol. 13 No. 2, 2014: 256-264 Cold storage of liver microorgans in ViaSpan® and BG35 solutions. Study of ammonia metabolism during normothermic reoxygenation María Dolores Pizarro,* María Gabriela Mediavilla,* Florencia Berardi,* Claudio Tiribelli,** Joaquín V Rodríguez,* María Eugenia Mamprin*** * Centro Binacional de Criobiología Clínica y Aplicada (CAIC), Universidad Nacional de Rosario, Arijón 28 bis, (2000) Rosario, Argentina. ** Centro Studi Fegato, AREA Science Park, Basovizza SS 14, Km 163,5. 34012 Trieste and Department of Medical Sciences, University of Trieste, Italy. *** Farmacología, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, S2002 LRK Rosario, Argentina. ABSTRACT Introduction. This work focuses on ammonia metabolism of Liver Microorgans (LMOs) after cold preserva- tion in a normothermic reoxygenation system (NRS). We have previously reported the development of a no- vel preservation solution, Bes-Gluconate-PEG 35 kDa (BG35) that showed the same efficacy as ViaSpan® to protect LMOs against cold preservation injury. The objective of this work was to study mRNA levels and activities of two key Urea Cycle enzymes, Carbamyl Phosphate Synthetase I (CPSI) and Ornithine Transcar- bamylase (OTC), after preservation of LMOs in BG35 and ViaSpan® and the ability of these tissue slices to detoxify an ammonia overload in a NRS model. Material and methods. After 48 h of cold storage (0°C in BG35 or ViaSpan®) LMOs were rewarmed in KHR containing an ammonium chloride overload (1 mM). We de- termined ammonium detoxification capacity (ADC), urea synthesis and enzyme activities and relative mRNA levels for CPSI and OTC. Results. At the end of reoxygenation LMOs cold preserved in BG35 have ADC and urea synthesis similar to controls.
    [Show full text]